Europe Animal Healthcare Market, by Animal Type (Livestock {Bovine, Porcine, Poultry, and Other} and Companion {Canine, Feline, and Equine}), by Route of Administration (Oral, Topical, and Injectable {Subcutaneous Injections, Intramuscular Injections, Int

Europe Animal Healthcare Market, by Animal Type (Livestock {Bovine, Porcine, Poultry, and Other} and Companion {Canine, Feline, and Equine}), by Route of Administration (Oral, Topical, and Injectable {Subcutaneous Injections, Intramuscular Injections, Intravenous Injections, Intra-peritoneal Injections, and Others}), by Indication (Infectious Diseases, Pain, Auto-immune Disease, and Others), and by Country (Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Animal healthcare includes veterinary and over-the-counter drugs, supplements, nutraceuticals, vaccines, antibiotics, and parasiticides, which are used in the treatment of diseases associated with the digestive system, immunological system, reproductive system, respiratory, and urinary system of animals. A rapid increase in the cases of zoonotic viral diseases and other animal-borne diseases can have adverse effects on farming and other occupation. Efficient animal healthcare can facilitate enhanced productivity of livestock to the farmers, as livestock animals provide a major protein source through meat and milk. Increasing public-private collaboration to increase awareness about efficient animal healthcare in Europe is expected to drive the Europe animal healthcare market growth.

Market Dynamics

Increasing product launches is responsible for the growth of the Europe animal healthcare market over the forecast period. For instance, Boehringer Ingelheim, a Germany-based pharmaceutical company, launched Fencovis, a new vaccine to prevent calf diarrhea. Boehringer Ingelheim is expanding its bovine vaccine portfolio with the introduction of Fencovis, a vaccine for the prevention of calf diarrhea that provides passive immunity to calves via the cows' maternal colostrum. Calf diarrhea, often known as calf scour, is a symptom of a variety of gastrointestinal illnesses that affect newborn calves who have not yet been weaned. Neonatal calf's undeveloped immune system, which is unable to create its own antibodies, makes calf scour much more difficult to treat.

Key features of the study:

• This report provides an in-depth analysis of the Europe animal healthcare market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Europe animal healthcare market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Merck & Co., Inc., Virbac, Dechra Pharmaceuticals Plc., Vetoquinol S.A., Zoetis Inc., Ceva Santé Animale, Bayer AG, Elanco, Evonik Industries AG, and Archer Daniels Midland Company
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The Europe animal healthcare market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Europe animal healthcare market

Detailed Segmentation:

• Europe Animal Healthcare Market, By Animal Type:
• Livestock
• Bovine
• Porcine
• Poultry
• Other
• Companion
• Canine
• Feline
• Equine
• Europe Animal Healthcare Market, By Route of Administration:
• Oral
• Topical
• Injectable
• Subcutaneous Injections
• Intramuscular Injections
• Intravenous Injections
• Intra-peritoneal Injections
• Others
• Europe Animal Healthcare Market, By Indication:
• Infectious Diseases
• Pain
• Auto-immune Disease
• Others
• Europe Animal Healthcare Market, By Country:
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Company Profiles
• Merck & Co., Inc.*
• Company Highlights
• Products Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Virbac
• Dechra Pharmaceuticals Plc.
• Vetoquinol S.A.
• Zoetis Inc.
• Ceva Santé Animale
• Bayer AG
• Elanco
• Evonik Industries AG
• Archer Daniels Midland Company

“*” marked represents similar segmentation in other categories in the respective section.